Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 26% ± 12% |
Insufficient scRNA-seq data for expression of PRXL2B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 2370.94 | 966 / 966 | 100% | 72.00 | 527 / 527 |
brain | 100% | 2641.83 | 2641 / 2642 | 100% | 34.86 | 703 / 705 |
stomach | 100% | 1378.75 | 359 / 359 | 100% | 71.41 | 285 / 286 |
skin | 100% | 1079.68 | 1804 / 1809 | 99% | 54.81 | 469 / 472 |
esophagus | 100% | 1173.49 | 1445 / 1445 | 98% | 43.13 | 180 / 183 |
breast | 99% | 1243.67 | 456 / 459 | 99% | 47.42 | 1104 / 1118 |
thymus | 100% | 1120.04 | 653 / 653 | 98% | 20.04 | 593 / 605 |
bladder | 100% | 1389.14 | 21 / 21 | 98% | 42.32 | 493 / 504 |
prostate | 100% | 1355.87 | 245 / 245 | 97% | 31.64 | 487 / 502 |
ovary | 97% | 764.54 | 175 / 180 | 100% | 43.79 | 429 / 430 |
lung | 100% | 1555.58 | 578 / 578 | 97% | 34.13 | 1116 / 1155 |
kidney | 100% | 1730.38 | 89 / 89 | 96% | 32.04 | 869 / 901 |
uterus | 99% | 1110.28 | 168 / 170 | 96% | 31.13 | 440 / 459 |
pancreas | 91% | 504.50 | 297 / 328 | 98% | 58.92 | 174 / 178 |
adrenal gland | 100% | 2107.08 | 258 / 258 | 87% | 24.29 | 199 / 230 |
liver | 89% | 483.35 | 202 / 226 | 70% | 14.56 | 283 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 53.36 | 80 / 80 |
spleen | 100% | 2048.77 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.86 | 1 / 1 |
adipose | 100% | 982.84 | 1200 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 26.51 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 25.76 | 27 / 29 |
heart | 90% | 469.50 | 776 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 86% | 519.65 | 1154 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 682.95 | 756 / 929 | 0% | 0 | 0 / 0 |
muscle | 3% | 10.38 | 23 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001516 | Biological process | prostaglandin biosynthetic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0043209 | Cellular component | myelin sheath |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0016616 | Molecular function | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
GO_0047017 | Molecular function | prostaglandin F synthase activity |
Gene name | PRXL2B |
Protein name | Prostamide/prostaglandin F synthase (EC 1.11.1.20) (Peroxiredoxin-like 2B) Prostamide/prostaglandin F synthase (Prostamide/PG F synthase) (Prostamide/PGF synthase) (EC 1.11.1.20) (Peroxiredoxin-like 2B) (Protein FAM213B) |
Synonyms | FAM213B C1orf93 |
Description | FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha) (By similarity). . FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha). . FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha). . FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha). . FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha). . FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha). . FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha). . FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha). . FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha). . FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha). . FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha). . FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha). . |
Accessions | ENST00000616280.4 ENST00000630439.2 ENST00000627654.2 ENST00000444521.6 ENST00000498083.2 J3KPF5 ENST00000630935.2 J3KRV9 ENST00000419916.8 [Q8TBF2-1] ENST00000465233.6 ENST00000378424.9 [Q8TBF2-7] ENST00000626354.2 ENST00000378427.6 [Q8TBF2-2] ENST00000628389.2 A0A2P0CU24 A0A0A0MRV4 A0A0A0MT35 J3KPF6 A0A2P0CTH9 ENST00000537325.6 A0A2P0CTB1 A0A0G2JRR6 ENST00000378425.9 ENST00000629512.2 J3QKK8 ENST00000617400.1 Q8TBF2 A0A0G2JSF1 |